[1] |
Wang M, Qiu R, Gong Z, et al. MiR⁃188⁃5p emerges as an oncomiRNA to promote gastric cancer cell proliferation and migration via upregulation of SALL4[J]. J Cell Biochem, 2019, 120(9):15027⁃15037. doi: 10.1002/jcb.28764.
|
[2] |
Meng Y, Xu X, Luan H, et al. The progress and development of GLUT1 inhibitors targeting cancer energy metabolism[J]. Future Med Chem, 2019, 11(17):2333⁃2352. doi: 10.4155/fmc⁃2019⁃0052.
|
[3] |
Peng Y, Shen X, Jiang H, et al. MiR⁃188⁃5p suppresses gastric cancer cell proliferation and invasion via targeting ZFP91[J]. Oncol Res, 2018,27(1):65⁃71. doi: 10.3727/096504018X151912 23015016.
|
[4] |
Li N, Shi H, Zhang L, et al. MiR⁃188 inhibits glioma cell proliferation and cell cycle progression through targeting β⁃catenin[J]. Oncol Res, 2018,26(5):785⁃794. doi: 10.3727/0965 04017X15127309628257.
|
[5] |
Yang M, Li Y, Wei W. MicroRNA⁃188⁃5p promotes epithelial⁃mesenchymal transition by targeting ID4 through Wnt/β⁃catenin signaling in retinoblastoma[J]. Onco Targets Ther, 2019,12:10251⁃10262. doi: 10.2147/OTT.S229739.
|
[6] |
Fang F, Chang RM, Yu L, et al. MicroRNA⁃188⁃5p suppresses tumor cell proliferation and metastasis by directly targeting FGF5 in hepatocellular carcinoma[J]. J Hepatol, 2015,63(4):874⁃885. doi: 10.1016/j.jhep.2015.05.008.
|
[7] |
Zhu X, Qiu J, Zhang T, et al. MicroRNA⁃188⁃5p promotes apoptosis and inhibits cell proliferation of breast cancer cells via the MAPK signaling pathway by targeting Rap2c[J]. J Cell Physiol, 2020,235(3):2389⁃2402. doi: 10.1002/jcp.29144.
|
[8] |
Nie ZY, Yang L, Liu XJ, et al. Morin inhibits proliferation and induces apoptosis by modulating the miR⁃188⁃5p/PTEN/AKT regulatory pathway in CML cells[J]. Mol Cancer Ther, 2019,18(12):2296⁃2307. doi: 10.1158/1535⁃7163.MCT⁃19⁃0051.
|
[9] |
Zhang H, Qi S, Zhang T, et al. miR⁃188⁃5p inhibits tumour growth and metastasis in prostate cancer by repressing LAPTM4B expression[J]. Oncotarget, 2015, 6(8):6092⁃6104. doi: 10.18632/oncotarget.3341.
|
[10] |
Li Y, Yan X, Shi J, et al. Aberrantly expressed miR⁃188⁃5p promotes gastric cancer metastasis by activating Wnt/β⁃catenin signaling[J]. BMC Cancer, 2019, 19(1):505. doi: 10.1186/s12885⁃019⁃5731⁃0.
|
[11] |
Hamid AA, Gray KP, Shaw G, et al. Compound genomic alterations of TP53, PTEN, and RB1 tumor suppressors in localized and metastatic prostate cancer[J]. Eur Urol, 2019,76(1):89⁃97. doi: 10.1016/j.eururo.2018.11.045.
|
[12] |
Wang Y, Yang J, Sheng W, et al. Adenovirus⁃mediated ING4/PTEN double tumor suppressor gene co⁃transfer modified by RGD enhances antitumor activity in human nasopharyngeal carcinoma cells[J]. Int J Oncol, 2015,46(3):1295⁃1303. doi: 10.3892/ijo.2015.2822.
|
[13] |
Mardente S, Mari E, Massimi I, et al. HMGB1⁃induced cross talk between PTEN and miRs 221/222 in thyroid cancer[J]. Biomed Res Int, 2015, 2015:512027. doi: 10.1155/2015/512027.
|
[14] |
Liang F, Cui ZJ, Liu JD, et al. Downregulated miR⁃328 suppressed cell invasion and growth in hepatocellular carcinoma via targeting PTEN[J]. Eur Rev Med Pharmacol Sci, 2018, 22(19):6324⁃6332. doi: 10.26355/eurrev_201810_16043.
|
[15] |
Jiang Y, Chang H, Chen G. Effects of microRNA⁃20a on the proliferation, migration and apoptosis of multiple myeloma via the PTEN/PI3K/AKT signaling pathway[J]. Oncol Lett, 2018, 15(6):10001⁃10007. doi: 10.3892/ol.2018.8555.
|
[16] |
Zhang L, Li C, Cao L, et al. MicroRNA⁃877 inhibits malignant progression of colorectal cancer by directly targeting MTDH and regulating the PTEN/Akt pathway[J]. Cancer Manag Res, 2019, 11:2769⁃2781. doi: 10.2147/CMAR.S194073.
|